- Home
- AVT vs AXSM Comparison
AVT vs AXSM Comparison
Compare AVT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVT
- AXSM
- Stock Information
- Founded
- AVT 1921
- AXSM 2012
- Country
- AVT United States
- AXSM United States
- Employees
- AVT N/A
- AXSM N/A
- Industry
- AVT Electronic Components
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- AVT Technology
- AXSM Health Care
- Exchange
- AVT Nasdaq
- AXSM Nasdaq
- Market Cap
- AVT 4.3B
- AXSM 5.1B
- IPO Year
- AVT N/A
- AXSM 2015
- Fundamental
- Price
- AVT $53.64
- AXSM $118.63
- Analyst Decision
- AVT Sell
- AXSM Strong Buy
- Analyst Count
- AVT 3
- AXSM 17
- Target Price
- AVT $49.00
- AXSM $175.76
- AVG Volume (30 Days)
- AVT 1.1M
- AXSM 578.6K
- Earning Date
- AVT 10-29-2025
- AXSM 11-11-2025
- Dividend Yield
- AVT 2.46%
- AXSM N/A
- EPS Growth
- AVT N/A
- AXSM N/A
- EPS
- AVT 2.75
- AXSM N/A
- Revenue
- AVT $22,200,754,000.00
- AXSM $495,033,000.00
- Revenue This Year
- AVT $5.51
- AXSM $63.78
- Revenue Next Year
- AVT $6.01
- AXSM $55.74
- P/E Ratio
- AVT $19.51
- AXSM N/A
- Revenue Growth
- AVT N/A
- AXSM 69.83
- 52 Week Low
- AVT $39.22
- AXSM $75.56
- 52 Week High
- AVT $59.24
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- AVT 50.63
- AXSM 51.88
- Support Level
- AVT $51.90
- AXSM $112.90
- Resistance Level
- AVT $54.15
- AXSM $130.00
- Average True Range (ATR)
- AVT 1.04
- AXSM 3.80
- MACD
- AVT -0.07
- AXSM -1.35
- Stochastic Oscillator
- AVT 56.51
- AXSM 33.51
About AVT Avnet Inc.
Avnet Inc is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribution. Avnet services all levels of electronics design and development, servicing engineers with design tools, test kits, and services alongside its high-volume distribution for final designs.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.